Factors associated with non-adherence and misuse of opioid maintenance treatment medications and intoxicating drugs among Finnish maintenance treatment patients
- 1 May 2016
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 162, 227-235
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non‐adherence and aberrant medication‐related behavioursDrug and Alcohol Review, 2011
- Self-treatment: Illicit buprenorphine use by opioid-dependent treatment seekersJournal of Substance Abuse Treatment, 2010
- Intravenous Misuse of BuprenorphineClinical Drug Investigation, 2010
- Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine‐maintained intravenous heroin abusersAddiction, 2010
- Diversion and Injection of Methadone and Buprenorphine Among Clients in Public Opioid Treatment Clinics in New South Wales, AustraliaSubstance Use & Misuse, 2009
- Buprenorphine in primary care: Risk factors for treatment injection and implications for clinical managementDrug and Alcohol Dependence, 2008
- Methadone Versus Buprenorphine With Contingency Management or Performance Feedback for Cocaine and Opioid DependenceAmerican Journal of Psychiatry, 2005
- Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?Addiction, 2005
- Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in FranceAddiction, 2003
- Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in FranceDrug and Alcohol Dependence, 2003